Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-09

Clinical Trial Update: Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing 1- and 2-week eradication regimens for Helicobacter pylori infection; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St.Paul's Hospital, Korea | Conditions: H.Pylori Gastrointestinal Disease | Phase 4 | Status: COMPLETED